Infectious Diseases Clinic, 3rd Floor, “VEDANTA” Institute of Medical
Sciences. Navarangpura. Ahmedabad. 380 009
Email: atulpatel65@gmail.com
EDUCATION
INSTITUTION AND LOCATION
DEGREE CONFERRED
YEAR
FIELD OF STUDY
B.J.Medical College, Ahmedabad, India.
MD
1992
MEDICINE
B.J.Medical College, Ahmedabad, India.
M.B., B.S.,
1987
PROFESSIONAL APPOINTMENTS:
Hon. Assistant Professor in Medicine, NHL Municipal Medical College & KM School of Postgraduate medical studies & research. Ahmedabad, India, February. ’94 – September 2000
Full time Assistant Professor in Medicine, BJ Medical College & Civil Hospital. Ahmedabad. November ’92 – January ‘94
Visiting Assistant Prof. in Medicine, Division of Infectious Diseases, University of South Florida, Tampa, FL. USA, From 2007 on wards
CERTIFICATIONS:
MD General medicine, Gujarat University, 1992
M.B., B.S., Gujarat University, 1987
AAHIVS, Americal Academy of HIV Medicine, 2008
A. PUBLICATIONS: Selected peer-reviewed publications (in chronological order).
Patel AK, Kazi BC. Resistant Salmonella meningitis treated with oflaxacin-a quinolone compound. J Assoc Physicians India. 1994;42(3):262.
Patel AK, HIV-Primary care approach & Management. Gujarat Medical Journal. 1997;53:3-9.
Patel AK, Talati S. B-19 Parvovirus infection as a cause of severe anemia in an HIV Infected Patient, case report. Indian Journal of Hematology and Blood Transfusion. 1998;26(1):38-39.
Patel AK. Prevention of maternal-child HIV transmission. Obstetrices and Gynocology Communications. 2000;2(5):29-39.
Patel AK. Antiretroviral treatment. Journal of Internal Medicine of India. 2001;4(2):83-85.
Patel AK. Fungal Infections in AIDS. Journal of Internal Medicine of India. 2001;4(1):44-47.
Banker AS, Patel AK. Effect of combination antiretroviral therapy on cytomegalovirus retinitis. Indian J Ophtalmol. 2002;50(1):29-33.
Patel AK, Patel K, Patel J, et al. Study on safety and antiretroviral effectiveness on concomitant use of rifampicin and efavirenz in antiretroviral naive tuberculosis co-infected HIV-1 patients in India. JAIDS. 2004;37(1):1166-1169.
Pujari S, Patel AK, Eknath N et al. Effectiveness of generic Fixed dose combinations of HAART for treatment of HIV infections in India. JAIDS. 2004: 37:1566-1569.
Patel AK, Patel K, Patel J. Lactic acidosis in HIV-1 infected patients receiving antiretroviral therapy. Journal of Association of Physicians of India . 2004;52:666-669.
Hatzakis GE, Mathur M, Gilbert I, Panos G, Wanchu A, Patel AK, Maniar JK, Tsoukas CM. Neutral network longitudinal assessment of the Electronic Anti-Retroviral Therepy (EARTH) cohort to follow response to HIV-treatment. American Medical Informatics Association Annual Symposium Proceedings. 2005; 301-305.
Gupta SB, Pujari SN, Joshi SR, Patel AK, for expert panel of Guidelines Development Committee. API Consensus Guidelines for use of Antiretroviral Therepy in Adults (API-ART Guidelines). Journal of Association of Physicians of India . 2006;54:57-74.
Patel AK, Patel KK. Future implications: Compliance and failures with antiretroviral treatment. Journal of Postgraduate Medicine. 2006; 52(3): 197-200.
Patel AK, Patel KK, Patel JK, Shrama RL, Ranjan RR. Effectiveness of low dose indinavirr/ritonavir (IDV/R) at 400/100 mg twice a day with two nucleoside reverse transcript inhinitor (nRTI) in non-nucleoside revrerse transcriptase inhibitor. (NNRTI) experienced HIV-1 infected patients in India –I year follow- up. JAIDS. 2006;43:1:124-126.
Patel AK, Patel KK, Shah SD, Desai J. Immune reconstitution syndrome presenting with cerebral varicella zoster vasculitis in HIV-1 infected patient: A case report. Journal of International Association of Physicians in AIDS CARE 2006;5(4):157-160.
Patel AK, S Pujari, K Patel et al Nevirapine Versus Efavirenz Based Antiretroviral Treatment in Naïve Indian Patients : Comparison of Effectiveness in Clinical Cohort: JAPI; 54: 915-918; Dec 2006
Sanjay Pujari, Atul Patel et al. Guidelines for Use of Antiretroviral Therapy for HIV
Infected Individuals in India (ART Guidelines 2008). JAPI ; VOL. 56: 339 – 372;
MAY 2008
Patel AK, Patel KK, Sharma RL, Shukla RK, Ranjan RR, Patel JA. Prevention of
mother to child HIV transmission using three drug combination antiretroviral
treatments: Observational cohort in clinical practice setting in India” JAIDS; 2009, Vol.
50: 231-232
. Ketan K. Patel, Atul K. Patel, Parimal Sarda et al. J. Immune Reconstitution Visceral
Leishmaniasis Presented as Hemophagocytic Syndrome in a Patient With AIDS
From a Nonendemic Area: A Case Report Journal of International Association of
Physicians in AIDS CARE 2009; 8(4):217-220.
Singh M, Kochhar P, Suvarna V, Patel A. Use of cefoperazone-sulbactum 2:1 in
patients with compromised renal function. Pharmacologyonline 3: 597-605 (2009)
CHAPTERS AND MONOGRAPHS:
Laboratory diagnosis of HIV infection; 7Th Edition, 2003; API Text Book of Medicine, Editor Dr. Siddharth Shah.
Opportunistic Infections In HIV: 8th Edition, 2008, API Text Book of Medicine, Editor Dr. Siddharth Shah.
Antibiotics In Clinical Practice; 1st Edition, 2008; Clinical G.I.Surgery, Editor Dr. Sanjiv Haribhakti
HIV infected Patient; 1st Edition, 2008; Clinical G.I.Surgery, Editor Dr. Sanjiv Haribhakti
SELECTED NON-PUBLISHED SCHOLARLY ACTIVITIES:
Invited in a capacity of temporary adviser to WHO Headquarter Geneva for fix drug combination in treatment of HIV/AIDS, Tb and malaria. December 2003.
Invited speaker, 2nd Update in HIV medicine, Pune, January 2003.
Invited speaker to conduct workshop for college of physicians and college of dermato-venereologist association of Sri Lanka- at Sri Lanka February, 2002
Invited to conduct CME for consultants at Kano and Lagos, Nigeria, September, 2002
Invited speaker, at Lucknow and Jaipur for SHARE program from IAS (International AIDS Society) 2000.
Invited speaker, for AIDS INDIA 2000 at Chennai, year 1997, 1999,2000
Invited for conducting workshop on HIV update at Mauritius, 29-30 March 2003
PRESENTATIONS AT CONFERENCE:
Analysis of presenting symptom complex & clinical features of HIV positive subjects in Gujarat - INDIA. 7- 12 July 96. 11th International Conference on AIDS. Vancouver, CANADA.abstract # Mo.B 1334.
HIV Disease - Clinical spectrum in state of Gujarat- INDIA. 10th International Conference on AIDS, Yokohama, Japan 94. Abstract # PB 0028.
Neurological presentations of HIV disease. Association of Physicians of India API CON - Jan. 96 Katmandu, Nepal.
HIV/AIDS our experience at civil hospital Ahmedabad. : APG (Association of physicians of Gujarat) conf.(APG-CON) - Ahmedabad.Dec.92
Clinical presentation of HIV infected patients. APG-CON Jamnagar.Jan.95
Antiretroviral Therapy. APG-CON Baroda, Jan.96.
Neurological Complications of HIV infection. Study of 38 cases. APG 97 Surat. Best Paper award.
Presented paper “efficacy of co-trimaxazole DS (TMP/SMX DS) as a chronic suppressive treatment in patients successfully treated for CNS toxoplasmosis in HIV-1 infected patients” at 7the Western Pacific congress on chemotherapy and Infectious diseases at HongKong 10-15th December 2000.
Presented two papers, 1. Dual Epidemic in Gujarat Abstract # 1277 and Long-term follow-up of HIV-1 infected Patients on Antiretroviral combination Therapy. Abstract # 1274 at Sixth International congress on AIDS in ASIA and the PACIFIC; 5-10 October 2001, Melbourne Australia.
Safety, Tolerability, and Efficacy of Nevirapine-Based HAART amongst Antiretroviral Naïve HIV-1-Infected Patients in India Abstract # W 463, 9th Conferences on Retrovirus and opportunistic infection. Seattle, WA. USA. February 2002.
Seroprevalence of hepatitis B & C co-infection in HIV infected patients in Gujarat- India, First National conference on HIV & Hepatitis co-infection. Mumbai, India. January 2003.
Occurrence of the metabolic side effects of ART in HIV-1 infected patients in India. First National conference on HIV & Hepatitis co-infection. Mumbai, India. January 2003.
The safety and antiretroviral efficacy of concomitant use of rifampicin and efavirenz in antiretroviral-naïve tuberculosis co-infected HIV-1 patients in India, Abstarct # 138, oral presentation, 10th Conferences on Retrovirus and opportunistic infection. Boston, MA. USA. February 2003.
Nevirapine versus Efavirenz based antiretroviral treatment (ART) in naïve Indian patients: comparison of effectiveness in clinical cohort. 11th Conferences on Retrovirus and opportunistic infection. San Francisco, LA. USA. February 2004.
Lipodystrophy and Dyslipidemia among patients Taking HAART: First Study from India. 11th Conferences on Retrovirus and opportunistic infection. San Francisco, LA. USA. February 2004.
Safety and Immunological effectiveness of simplified Fixed dose combination of Nevirapine based HAART amongst Indian patients - Extended follow up data; 2nd IAS conference, Paris, July 2003
Quantitative immunological response to HAART is similar even when initiated late: Experience from an Indian cohort. XV international AIDS conference, Bangkok. 2004. Abstract # [B11380]
Study of long term metabolic and morphological side effects of antiretroviral therapy in HIV-1 infected Indian patients. XV international AIDS conference, Bangkok. July 2004. Abstract # [B10163]
Lympho-reticular malignancies in HIV-1infected patients: Indian experience European Society for Medical Oncology Congress, Vienna, poster # 600. November - 2004
Effectiveness of Generic Efavirenz based HAART in HIV-1 infected patients in India: A 2 years Follow-up. 12th CROI, Abstract # 630, February, 2005 Boston, MA, USA
Effectiveness of low dose indinavir/ritonavir (IDV/r) at 400/100mg twice a day with two nucleoside reverse transcriptase inhibitors (nRTI) in non nucleoside reverse transcriptase inhibitor (NnRTI) experienced HIV-1 infected patients in INDIA - 1 year follow-up. Abstract # MoPp 0306, 3rd IAS conference on HIV pathogenesis and Treatment. 24 – 27 July 2005, Rio de Janerio, Brazil.
Gender Difference In Immunological Response To Non Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Based Regimen In HIV-1 Infected Indian Patients. Eighth International Congress on Drug therapy in HIV Infection, Poster# 950486, Glasgow, UK. 12-16 Nov. 2006
TB co-infection treated at onset of therapy does not affect long-term risk of treatment failure among HIV-1 patients initiating EFV-based combination antiretroviral treatment (cART) ACCEPTED FOR ORAL PRESENTATION AT 4th IAS conference on HIV pathogenesis and Treatment. 22 – 25 July 2007, Sydney, Australia
Myositis in HIV infected patients; challenges in diagnosis and management: report of 4 cases, Accepted for presentation at 19th World Congress of Neurology 24-30 Oct 2009, Bangkok. Thailand
Comparison of the effectiveness of low dose Indinavir/ritonavir (IDV/r) versus Atazanavir/ritonavir (ATV/r) based antiretroviral therapy in NNRTI experienced HIV-1 infected patients in India. 19th Conference of International Society of Infectious Diseases, Miami, Florida. 9 – 12th March 2010.
Awards:
Approach to Patients with PUO” - Rotating Lectureship Award for year 2002 at 24th Annual conference of Association of Physicians of Gujarat, 4-5th Jan 2003, Surat.
Ahmedabad Medical Association awarded for Outstanding Achievement in medical field for the year 2003 on 31/8/03
Nathubhai Patel Oration trophy for “HIV –Past, Present and Future” for the year 2005 at Annual conference of Association of Physicians of Gujarat December. Ahmedabad
P.R Trivedi oration Trophy for the Year 2005-2006 for “HIV- A Chronic Manageable Infection” at Annual IMA Gujarat State branch Conference at Surat, 25November 2006
Clinical trial experience
.
Post Marketing (Phase IV) study of Lamivudine (Epivir) GSK Protocol No : GWIND 01/99
EPI): Study Completed in 2000
Post marketing (Phase IV) study of Atazanavir: Study completed in 2007
A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and
Antiretroviral Activity of Study drug Versus Kaletra™ in HIV-Infected Patients Switched from a
Stable Kaletra™-Based Regimen - Study B : Completed studying 2009
A phase 2b/3, randomized, double blind, dose confirming study of the safety, efficacy and
tolerability of STUDY drug versus lamivudine in treatment-experienced HIV-1 infected
patients with the M184V/I mutation in reverse transcriptase. : About to start recruitment
